A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of mi...
Guardado en:
Autores principales: | Zhongjian Chen, Chenxi Yang, Zhenying Guo, Siyu Song, Yun Gao, Ding Wang, Weimin Mao, Junping Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d667ec7deb8b4f9ebcd02aef60446ca3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
por: Giuseppe Mangiameli, et al.
Publicado: (2021) -
Diagnostic yield and safety of closed needle pleural biopsy in exudative pleural effusion
por: Govind Singh Rajawat, et al.
Publicado: (2017) -
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Hiroto Yoneda, et al.
Publicado: (2021) -
Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
por: Joman Javadi, et al.
Publicado: (2021) -
MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
por: Wang Pei, et al.
Publicado: (2021)